ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,699Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 223

$688K Total Retail Price of All Prescriptions

Rank: 30 out of 223

623 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 623 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 623 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 9,424 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
LEVOTHYROXINE SODIUM 576 538 1 2
HYDROCODONE-ACETAMINOPHEN 438 365 S3 2 5
OMEPRAZOLE 408 369 3 3
SIMVASTATIN 406 393 4 1
LISINOPRIL 337 311 5 4
ALENDRONATE SODIUM 258 247 6 19
GABAPENTIN 251 241 7 10
FUROSEMIDE 230 188 8 9
AMLODIPINE BESYLATE 203 192 9 6
FLUOXETINE HCL 201 152 10 24
MELOXICAM 194 192 11 33
ZOLPIDEM TARTRATE 179 143 12 8
TRAMADOL HCL 177 161 13 18
PRAVASTATIN SODIUM 168 153 14 15
WARFARIN SODIUM 163 161 15 11
POTASSIUM CHLORIDE 132 122 16 12
LOSARTAN POTASSIUM 124 124 17 14
METFORMIN HCL 124 99 17 7
METOPROLOL TARTRATE 122 115 19 25
PANTOPRAZOLE SODIUM 91 79 20 45
SERTRALINE HCL 89 71 21 21
TAMSULOSIN HCL 88 86 22 26
ADVAIR DISKUS 87 80 23 47
KLOR-CON M20 84 62 24 67
METOPROLOL SUCCINATE 78 64 25 20
LYRICA 75 68 26 84
IBUPROFEN 71 57 27 46
ATORVASTATIN CALCIUM 70 63 28 17
CLOPIDOGREL 69 58 29 56
ALLOPURINOL 67 63 30 28
CRESTOR 66 65 31 37
AZITHROMYCIN 66 64 31 44
NEXIUM 63 50 33 49
ESTRADIOL 61 57 R 34 59
CELEBREX 60 60 35 42
OXYCODONE-ACETAMINOPHEN 59 44 S2 36 116
CARISOPRODOL 58 54 R 37 63
ATENOLOL 56 54 38 32
DONEPEZIL HCL 56 56 38 36
CIPROFLOXACIN HCL 56 56 38 53
FLUTICASONE PROPIONATE 56 43 38 27
FINASTERIDE 55 53 42 58
NAMENDA 55 55 42 48
PLAVIX 55 45 42 85
DIGOXIN 52 52 45 73
ROPINIROLE HCL 51 32 46 62
CITALOPRAM HBR 50 38 47 16
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.